Kindstar Globalgene Technology (HKSE:09960) Change In Receivables : HK$-71 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Change In Receivables?

Kindstar Globalgene Technology's change in receivables for the quarter that ended in Jun. 2023 was HK$47 Mil. It means Kindstar Globalgene Technology's Accounts Receivable declined by HK$47 Mil from Dec. 2022 to Jun. 2023 .

Kindstar Globalgene Technology's change in receivables for the fiscal year that ended in Dec. 2022 was HK$-356 Mil. It means Kindstar Globalgene Technology's Accounts Receivable increased by HK$356 Mil from Dec. 2021 to Dec. 2022 .

Kindstar Globalgene Technology's Accounts Receivable for the quarter that ended in Jun. 2023 was HK$715 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Kindstar Globalgene Technology's Days Sales Outstanding for the six months ended in Jun. 2023 was 242.16.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kindstar Globalgene Technology's liquidation value for the six months ended in Jun. 2023 was HK$2,011 Mil.

Kindstar Globalgene Technology Change In Receivables Historical Data

The historical data trend for Kindstar Globalgene Technology's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Change In Receivables Chart

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-44.46

-94.25

-46.47

-355.59

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial					-10.40	-248.99	-118.38	47.46	-

Kindstar Globalgene Technology Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-71 Mil.

Kindstar Globalgene Technology (HKSE:09960) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kindstar Globalgene Technology's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	715.176	/	538.971	*	91
=	242.16

2. In Ben Graham's calculation of liquidation value, Kindstar Globalgene Technology's accounts receivable are only considered to be worth 75% of book value:

Kindstar Globalgene Technology's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2357.19	-	910.763	+	0.75 * 715.176	+	0.5 * 56.36
=	2,011

Kindstar Globalgene Technology Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology (HKSE:09960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines